A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Viewers are urged to message these profiles privately for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors promote the drug there before directing customers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Experts Voice Concerns
However, physicians and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could lead to individuals administering substances of unknown origin.
Some professionals stated the popularity for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Content Removal
Based on TikTok, the service has removed violative content and banned associated keywords and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.
Digital Marketplace Operations
Research also found communities with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly displays groups with numerous of members, populated with images of slimming results, glowing reviews and step-by-step guides for preparing or administering at home.
Within moments of joining one group, a seller shared contact information, where most transactions take place. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about body mass, medical conditions or previous experience.
Item Details and Costs
Within these communities, messages display black plastic packages with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for the messaging service said it regularly moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they can’t verify. Even if the science behind this drug is valid, these digital products may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her staff has already encountered individuals injured by self-injection from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to possibly serious medical dangers”.
